FRACTION IV-1 PASTE SUPPLY AGREEMENTFraction Iv-1 Paste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • London
Contract Type FiledApril 11th, 2013 Company Industry JurisdictionThis Fraction IV-1 Paste Supply Agreement is entered into, and effective as of this 3rd day of December, 2012 (“Effective Date”), by and between Baxter Healthcare S.A., a Swiss entity, having a place of business at Postfach, 8010 Zurich, Switzerland (“Baxter”) and Kamada Ltd., having a place of business at 7 Sapir St. Kiryat Weizmann, Ness-Ziona 74036, Israel (“Kamada”).
AMENDED AND RESTATED FRACTION IV-1 PASTE SUPPLY AGREEMENTFraction Iv-1 Paste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
Contract Type FiledApril 11th, 2013 Company Industry JurisdictionThis Amended and Restated Fraction IV-1 Paste Supply Agreement (this “Agreement”) is entered into, and effective as of 5:00 PM Eastern Daylight Time, August 23, 2010 (the “Effective Date”), by and between Baxter Healthcare Corporation, a Delaware corporation, having a place of business at One Baxter Way, Westlake Village, California 91361 (“Baxter”) and Kamada Ltd., having a place of business at 7 Sapir St. Kiryat Weizmann, Ness-Ziona 74036, Israel (“Kamada”). Baxter and Kamada are each referred to herein as a “Party” and collectively as the “Parties”.
SECOND AMENDMENT TO THE AMENDED AND RESTATED FRACTION IV-1 PASTE SUPPLY AGREEMENTFraction Iv-1 Paste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledApril 11th, 2013 Company IndustryThis Second Amendment to the Amended and Restated Fraction IV-1 Paste Supply Agreement (“Second Amendment”) effective this 22nd day of June, 2011 (“Effective Date”), by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “BAXTER”), and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “KAMADA”). BAXTER and KAMADA shall collectively be referred to as the “Parties”.
THIRD AMENDMENT TO THEFraction Iv-1 Paste Supply Agreement • February 25th, 2016 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledFebruary 25th, 2016 Company Industry
FIRST AMENDMENT TO THE AMENDED AND RESTATED FRACTION IV-1 PASTE SUPPLY AGREEMENTFraction Iv-1 Paste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledApril 11th, 2013 Company IndustryThis First Amendment to the Amended and Restated Fraction IV-1 Paste Supply Agreement (“First Amendment”) effective this 10th day of May, 2011 (“Effective Date”), by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “BAXTER”), and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “KAMADA”). BAXTER and KAMADA shall collectively be referred to as the "Parties”.